Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh

Authors: Md Jasim Uddin, Gourab Adhikary, Md Wazed Ali, Shahabuddin Ahmed, Md Shamsuzzaman, Chris Odell, Lauren Hashiguchi, Stephen S. Lim, Nurul Alam

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Like other countries in Asia, measles-rubella (MR) vaccine coverage in Bangladesh is suboptimal whereas 90–95 % coverage is needed for elimination of these diseases. The Ministry of Health and Family Welfare (MOHFW) of the Government of Bangladesh implemented MR campaign in January-February 2014 to increase MR vaccination coverage. Strategically, the MOHFW used both routine immunization centres and educational institutions for providing vaccine to the children aged 9 months to <15 years. The evaluation was carried out to assess the impact of the campaign on MR vaccination and routine immunization services.

Methods

Both quantitative and qualitative evaluations were done before and after implementation of the campaign. Quantitative data were presented with mean (standard deviation, SD) for continuous variables and with proportion for categorical variables. The overall and age- and sex-specific coverage rates were calculated for each region and then combined. Categorical variables were compared by chi-square statistics. Multiple logistic regression analysis were performed to estimate odds ratios (OR) and 95 % confidence intervals (CI) of coverage associated with covariates, with adjustment for other covariates. Qualitative data were analyzed using content analysis.

Results

The evaluations found MR coverage was very low (<13 %) before the campaign and it rose to 90 % after the campaign. The pre-post campaign difference in MR coverage in each stratum was highly significant (p < 0.001). The campaign achieved high coverage despite relatively low level (23 %) of interpersonal communication with caregivers through registration process. Child registration was associated with higher MR coverage (OR 2.91, 95 % CI 1.91–4.44). Children who attended school were more likely to be vaccinated (OR 8.97, 95 % CI 6.17–13.04) compared to those who did not attend school. Children of caregivers with primary or secondary or higher education had higher coverage compared to children of caregivers with no formal education. Most caregivers mentioned contribution of the campaign in vaccination for the children not previously vaccinated.

Conclusions

The results of the evaluation indicated that the campaign was successful in terms of improving MR coverage and routine immunization services. The evaluation provided an important guideline for future evaluation of similar efforts in Bangladesh and elsewhere.
Literature
1.
go back to reference Cutts FT. The Immunological Basis for Immunization Series, Module 7: Measles. Geneva: WHO Gpfvai; 1993. Cutts FT. The Immunological Basis for Immunization Series, Module 7: Measles. Geneva: WHO Gpfvai; 1993.
2.
go back to reference Hutchins SS, Redd SC, Schrag S, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. MedGenMed. 2001: E5. Hutchins SS, Redd SC, Schrag S, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. MedGenMed. 2001: E5.
3.
go back to reference World Health Organization Measles vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84(35):349–60. World Health Organization Measles vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84(35):349–60.
4.
go back to reference World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301–16. World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301–16.
8.
go back to reference Koehlmoos TP, et al. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh. J Infect Dis. 2011;204:S90–7. Koehlmoos TP, et al. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh. J Infect Dis. 2011;204:S90–7.
10.
go back to reference World Health Organization. Bangladesh introduces new MR and MCV2 vaccine to prevent Measles, Rubella & (Congenital Rubella Syndrome. EPI Surveillance bulletin. 2012;15(1):1–5. World Health Organization. Bangladesh introduces new MR and MCV2 vaccine to prevent Measles, Rubella & (Congenital Rubella Syndrome. EPI Surveillance bulletin. 2012;15(1):1–5.
11.
go back to reference World Health Organization. EPI Fact Sheet: Bangladesh 2011. 2012. World Health Organization. EPI Fact Sheet: Bangladesh 2011. 2012.
12.
go back to reference Fields R, Dabbagh A, Jain M, Sagar KS. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities. Vaccine. 2013;31(Supplement 2):B115–21.CrossRefPubMed Fields R, Dabbagh A, Jain M, Sagar KS. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities. Vaccine. 2013;31(Supplement 2):B115–21.CrossRefPubMed
13.
go back to reference Bino S, et al. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis. 2003;187(Supplement 1):S223–9.CrossRefPubMed Bino S, et al. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis. 2003;187(Supplement 1):S223–9.CrossRefPubMed
14.
go back to reference Directorate General of Health Services (DGHS). EPI coverage evaluation survey-2013. Government of Bangladesh: Ministry of Health and Family Welfare; 2013. Directorate General of Health Services (DGHS). EPI coverage evaluation survey-2013. Government of Bangladesh: Ministry of Health and Family Welfare; 2013.
15.
go back to reference Bond L, et al. Vaccine preventable diseases and immunisations: a qualitative study of mothers? Perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health. 1998;22(4):441–6.CrossRefPubMed Bond L, et al. Vaccine preventable diseases and immunisations: a qualitative study of mothers? Perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health. 1998;22(4):441–6.CrossRefPubMed
16.
go back to reference Mbabazi WB, et al. Achieving measles control: lessons from the 2002–06 measles control strategy for Uganda. Health Policy Plan. 2009;24(4):261–9.CrossRefPubMed Mbabazi WB, et al. Achieving measles control: lessons from the 2002–06 measles control strategy for Uganda. Health Policy Plan. 2009;24(4):261–9.CrossRefPubMed
17.
go back to reference Hanvoravongchai P, Mounier-Jack S, Cruz VO, et al. Impact of Measles Elimination Activities on Immunization Services and Health Systems: Findings From Six Countries. J Infect Dis. 2011;204:S82–9.CrossRefPubMed Hanvoravongchai P, Mounier-Jack S, Cruz VO, et al. Impact of Measles Elimination Activities on Immunization Services and Health Systems: Findings From Six Countries. J Infect Dis. 2011;204:S82–9.CrossRefPubMed
18.
go back to reference Mounier-Jack S, Burchett HED, Ulla Kou G, Mamadou K, Kassibo Sira D. Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system. Glob Health Sci Pract. 2014;2:117–29.CrossRefPubMedPubMedCentral Mounier-Jack S, Burchett HED, Ulla Kou G, Mamadou K, Kassibo Sira D. Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system. Glob Health Sci Pract. 2014;2:117–29.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh
Authors
Md Jasim Uddin
Gourab Adhikary
Md Wazed Ali
Shahabuddin Ahmed
Md Shamsuzzaman
Chris Odell
Lauren Hashiguchi
Stephen S. Lim
Nurul Alam
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1758-x

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.